Cargando…
Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017913/ https://www.ncbi.nlm.nih.gov/pubmed/33819577 http://dx.doi.org/10.1016/j.clim.2021.108720 |
_version_ | 1783674141692395520 |
---|---|
author | Perna, Francesco Bruzzaniti, Sara Piemonte, Erica Maddaloni, Valeria Atripaldi, Lidia Sale, Silvia Sanduzzi, Alessandro Nicastro, Carmine Pepe, Nicola Bifulco, Maurizio Matarese, Giuseppe Galgani, Mario Atripaldi, Luigi |
author_facet | Perna, Francesco Bruzzaniti, Sara Piemonte, Erica Maddaloni, Valeria Atripaldi, Lidia Sale, Silvia Sanduzzi, Alessandro Nicastro, Carmine Pepe, Nicola Bifulco, Maurizio Matarese, Giuseppe Galgani, Mario Atripaldi, Luigi |
author_sort | Perna, Francesco |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8017913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80179132021-04-02 Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients Perna, Francesco Bruzzaniti, Sara Piemonte, Erica Maddaloni, Valeria Atripaldi, Lidia Sale, Silvia Sanduzzi, Alessandro Nicastro, Carmine Pepe, Nicola Bifulco, Maurizio Matarese, Giuseppe Galgani, Mario Atripaldi, Luigi Clin Immunol Letter to the Editor Elsevier Inc. 2021-05 2021-04-02 /pmc/articles/PMC8017913/ /pubmed/33819577 http://dx.doi.org/10.1016/j.clim.2021.108720 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Perna, Francesco Bruzzaniti, Sara Piemonte, Erica Maddaloni, Valeria Atripaldi, Lidia Sale, Silvia Sanduzzi, Alessandro Nicastro, Carmine Pepe, Nicola Bifulco, Maurizio Matarese, Giuseppe Galgani, Mario Atripaldi, Luigi Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients |
title | Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients |
title_full | Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients |
title_fullStr | Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients |
title_full_unstemmed | Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients |
title_short | Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients |
title_sort | serum levels of sars-cov-2 nucleocapsid antigen associate with inflammatory status and disease severity in covid-19 patients |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017913/ https://www.ncbi.nlm.nih.gov/pubmed/33819577 http://dx.doi.org/10.1016/j.clim.2021.108720 |
work_keys_str_mv | AT pernafrancesco serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT bruzzanitisara serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT piemonteerica serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT maddalonivaleria serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT atripaldilidia serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT salesilvia serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT sanduzzialessandro serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT nicastrocarmine serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT pepenicola serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT bifulcomaurizio serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT mataresegiuseppe serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT galganimario serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients AT atripaldiluigi serumlevelsofsarscov2nucleocapsidantigenassociatewithinflammatorystatusanddiseaseseverityincovid19patients |